Intelligence · Clinical Pipeline
ALMIRALL S.P.A Pipeline
All ClinicalTrials.gov programs at ALMIRALL S.P.A — phase, modality, and trial IDs.
- Programs
- 4
Quick answer
ALMIRALL S.P.A has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Almax Forte 1,5 g suspensión oral
Almirall, S.A.
heartburn and or reflux
1 trial -
Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel
Almirall, S.A.
Actinic Keratosis
1 trial -
Pidotimod
Almirall, S.A.
Recurrent Respiratory Tract Infections
1 trial -
Toujeo
Almirall, S.A.
Diabetes Mellitus, Type 2
1 trial
Frequently asked questions
How many pipeline programs does ALMIRALL S.P.A have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs